Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
etarfolatide
- Development stage
- Phase 2
- Lead developer
- Novartis
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Administration
- Intravenous
01
Overview
Etarfolatide is a radiopharmaceutical imaging agent that targets the folate receptor. It consists of a small molecule conjugated to technetium-99m, enabling non-invasive identification of cells expressing the folate receptor, such as certain cancer and inflammatory cells. Etarfolatide is primarily used as a companion diagnostic to select patients with folate receptor-positive tumors who may benefit from targeted therapies like vintafolide. It has been investigated in clinical trials for platinum-resistant ovarian cancer (in combination with pegylated liposomal doxorubicin), non-small cell lung cancer, breast neoplasms, and other malignancies. The drug was developed by Endocyte and later by Novartis following acquisition.
- Brand names
- Folcepri
- Other names
- technetium Tc99m etarfolatideEC20 folate peptideEC-20 folate peptideEC 20 folate peptide
02
Targets
FOLR2 (Folate receptor beta)RFC1 (Reduced folate carrier type 1)FOLR1 (FRα)
Beyond the preview
Go deeper on etarfolatide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on etarfolatide.